ArticleNature communications2025
Genetic engineering of Sorangium cellulosum reveals hidden enzymology in myxobacterial natural product biosynthesis.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development of efficient genetic toolkits and heterologous chassis for bioprospecting of myxobacteria.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Sorangium cellulosum is a cellulolytic myxobacterium that produces a vast array of complex natural products with diverse chemical scaffolds and biological activities. However, biosynthetic investigations of these metabolites have been hindered by the scarcity of genetic manipulation tools available for their producing microorganisms. Here, we develop an efficient electroporation method for transforming foreign DNA into various Sorangium strains, enabling effective genetic engineering via homologous recombination. This facilitates delineation of the biosynthetic pathway to ambruticin, unveiling several previously undisclosed steps. Notably, AmbK is identified as the elusive epoxide hydrolase responsible for the formation of the tetrahydropyran ring during post-polyketide synthase (PKS) modification, while the terminal PKS module AmbH is shown to catalyse dual rounds of chain elongation during polyketide assembly. Our findings provide significant insights into the intricate molecular machinery governing myxobacterial natural product biosynthesis and greatly enhance our ability to further engineer Sorangium strains to unlock their biosynthetic potentials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.